Regulatory News Service Feed

Headline
Date
Download
PDMR Shareholding/Share Incentive Plan
January 30, 2023 17:01
USD 7m enterprise engagements for data services
January 26, 2023 07:01
Trading Statement and Strategy Update
January 26, 2023 07:01
PDMR Shareholding/Share Incentive Plan
January 03, 2023 07:01
Change of Auditor
November 29, 2022 07:11
PDMR Shareholding/Share Incentive Plan
November 29, 2022 07:11
Sub-optimal testing impacts on cancer patients
November 01, 2022 07:11
PDMR Shareholding/Share Incentive Plan
October 31, 2022 14:10
PDMR Shareholding/Share Incentive Plan
October 05, 2022 17:10
Purchase of Shares and PDMR Shareholding
October 05, 2022 07:10
Half-year Report
September 27, 2022 07:09
PDMR Shareholding/Share Incentive Plan
September 12, 2022 12:09
Notice of Results and Presentations
September 08, 2022 07:09
PDMR Shareholding/Share Incentive Plan
August 08, 2022 07:08
Trading Update and Notice of Results
July 26, 2022 07:07
PDMR Shareholding/Share Incentive Plan
July 22, 2022 17:07
Multi-year contract with top five global pharma
June 13, 2022 07:06
New AI and ML Capabilities Enhance DXRX Platform
June 07, 2022 07:06
PDMR Shareholding/Share Incentive Plan
May 31, 2022 12:05
Share Options and PDMR Shareholdings
May 27, 2022 16:05
Result of AGM
May 26, 2022 15:05
PDMR Shareholding/Share Incentive Plan
May 11, 2022 14:05
Exercise of Warrant & Total Voting Rights
May 09, 2022 16:05
Contract Win
May 05, 2022 07:05
PDMR Shareholding/Share Incentive Plan
April 29, 2022 17:04
Notice of AGM and Posting of Annual Report
April 28, 2022 14:04
Purchase and Sale of Shares and PDMR Shareholdings
April 07, 2022 07:04
PDMR Shareholding/Share Incentive Plan
April 06, 2022 13:04
Conversion of Convertible Loan Notes & TVR
April 05, 2022 15:04
Issue of Share Options / PDMR Shareholdings
April 01, 2022 07:04
PDMR Shareholding/Share Incentive Plan
March 31, 2022 17:03
Final Results
March 22, 2022 14:03
Notice of 2021 Full Year Results
March 22, 2022 07:03
Confirmation of Directorate Change
March 18, 2022 14:03
Holding(s) in Company
March 16, 2022 17:03
Approval by CMS for enhanced data access
March 16, 2022 07:03
PDMR Shareholding/Share Incentive Plan
March 02, 2022 17:03
Investor Presentation
February 21, 2022 07:02
PDMR Shareholding/Share Incentive Plan
February 14, 2022 18:02
Contract with leading life sciences company
February 14, 2022 07:02
Director/PDMR Shareholding
February 04, 2022 11:02
Directorate Change
January 11, 2022 07:01
Trading Update and Notice of Results
January 11, 2022 07:01
PDMR Shareholding/Share Incentive Plan
January 04, 2022 07:01
Contract Win
December 14, 2021 07:12
Test Signal Launch and Contract Wins
December 09, 2021 07:12
PDMR Shareholding/Share Incentive Plan
December 01, 2021 17:12
PDMR Shareholding/Share Incentive Plan
November 09, 2021 16:11
PDMR Shareholding/Share Incentive Plan
October 01, 2021 13:10
Holding(s) in Company
October 01, 2021 12:10
Purchase/Transfer of Shares and PDMR Shareholdings
September 28, 2021 07:09
Nominated as finalists for Health Tech Awards 2021
September 21, 2021 07:09
Half-year Report
September 14, 2021 07:09
DXRX Platform Contract Win
September 13, 2021 07:09
Two new experts join the Diaceutics Advisory Panel
September 08, 2021 07:09
PDMR Shareholding/Share Incentive Plan
September 01, 2021 07:09
Notice of Investor Presentation
August 31, 2021 07:08
PDMR Shareholding/Share Incentive Plan
July 30, 2021 16:07
Trading Update
July 08, 2021 07:07
Issue of Share Options and PDMR Shareholdings
July 01, 2021 07:07
PDMR Shareholding/Share Incentive Plan
June 29, 2021 16:06
New Contract Wins
June 24, 2021 07:06
Purchase of Shares and PDMR Shareholding
June 18, 2021 07:06
Capital Markets Day and KPI Update
June 16, 2021 07:06
PDMR Shareholding/Share Incentive Plan
June 07, 2021 18:06
Notice of Capital Markets Day
June 07, 2021 07:06
Presenting data on COVID impact on cancer at ASCO
June 04, 2021 07:06
Holding(s) in Company
May 21, 2021 13:05
Change of Adviser
May 21, 2021 07:05
Result of AGM
May 19, 2021 15:05
LGC SeraCare Partnership
May 13, 2021 07:05
Sale of Shares and PDMR Shareholding
May 12, 2021 17:05
Holding(s) in Company
May 05, 2021 18:05
Sale of Shares and Director/PDMR Shareholding
May 04, 2021 15:05
Share Incentive Plan
April 30, 2021 11:04
Notice of AGM and posting of Annual Report
April 21, 2021 07:04
New Vice President of Operations in Asia
April 12, 2021 07:04
Transfer of Shares and Director/PDMR Shareholding
April 08, 2021 09:04
Transfer of Shares and Director/PDMR Shareholding
April 07, 2021 07:04
Issue of Share Options/PDMR Shareholdings
April 06, 2021 11:04
COVID-19 Testing Data licensing agreement
April 01, 2021 07:04
New lease agreement and related party transaction
March 30, 2021 07:03
Final Results
March 15, 2021 07:03
Notice of Results
March 08, 2021 07:03
New Vice President of Finance appointment
March 04, 2021 12:03
Quarterly media update
January 21, 2021 07:01
Holding(s) in Company
January 11, 2021 09:01
Trading update
January 11, 2021 07:01
Directorate Change
December 22, 2020 07:12
Directorate Change
December 22, 2020 07:12
Holding(s) in Company
December 10, 2020 15:12
European international award win
November 17, 2020 07:11
Holding(s) in Company
November 10, 2020 16:11
Commercial launch of DXRX
October 28, 2020 07:10
Second Price Monitoring Extn
September 07, 2020 14:09
Price Monitoring Extension
September 07, 2020 14:09
Price Monitoring Extension
September 07, 2020 11:09
Half-year Report
September 07, 2020 07:09
Notice of Results
August 27, 2020 07:08
New contract win for DXRX platform
July 22, 2020 07:07
Holding(s) in Company
July 09, 2020 07:07
Trading update
July 08, 2020 07:07
Second Price Monitoring Extn
July 06, 2020 16:07
Price Monitoring Extension
July 06, 2020 16:07
Holding(s) in Company
July 03, 2020 10:07
Issue of Share Options
July 03, 2020 07:07
Result of General Meeting
June 29, 2020 14:06
Holding(s) in Company
June 19, 2020 07:06
Exercise of warrant
June 11, 2020 14:06
Placing of £20.5 million
June 11, 2020 07:06
Result of AGM
May 19, 2020 14:05
AGM Statement
May 19, 2020 07:05
Diagnostic network for precision medicine update
May 18, 2020 07:05
Cancer testing & diagnosis suffers sharp downturn
April 29, 2020 07:04
Posting of Annual Report and Notice of AGM
April 23, 2020 07:04
Issue of Share Options
April 06, 2020 07:04
Belfast investor presentation
March 19, 2020 07:03
Second Price Monitoring Extn
March 17, 2020 09:03
Price Monitoring Extension
March 17, 2020 09:03
Second Price Monitoring Extn
March 16, 2020 11:03
Price Monitoring Extension
March 16, 2020 11:03
Final Results
March 16, 2020 07:03
Private investor briefing
March 12, 2020 14:03
Notice of Results
February 27, 2020 07:02
Belfast investor presentation
February 17, 2020 07:02
Growth & Innovation Forum 2020
February 06, 2020 07:02
Holding(s) in Company
January 17, 2020 14:01
Second Price Monitoring Extn
January 13, 2020 09:01
Price Monitoring Extension
January 13, 2020 09:01
Year-End Trading Update
January 13, 2020 07:01
Presentation at AICon 2019
November 25, 2019 07:11
Presentation at Big Data Belfast
October 24, 2019 07:10
Pharma Precision Medicine Readiness Report
October 21, 2019 07:10
Workshop presentation at EORTC
October 10, 2019 07:10
Poster presentation at ESMO
September 30, 2019 08:09
Dublin investor presentation
September 23, 2019 07:09
Half-year Report
September 09, 2019 07:09
Notice of Results
August 08, 2019 07:08
Appointment of Head of Global Data
August 08, 2019 07:08
Trading update
July 08, 2019 07:07
Investment in data lake
June 17, 2019 07:06
Investor presentation
May 28, 2019 07:05
Holding(s) in Company
March 25, 2019 16:03
Holding(s) in Company
March 25, 2019 07:03
Second Price Monitoring Extn
March 21, 2019 14:03
Price Monitoring Extension
March 21, 2019 14:03
Admission to AIM & First Day of Dealings
March 21, 2019 07:03

Latest Investor News

News

Diaceutics provides trading statement for year ended 31 Dec 22
News

US$ 7 million multi-year enterprise engagements for subscription data services
Annual & Interim Reports

Interim Report June 2022
News

Diaceutics releases interim results for period ended 30 June 2022
Show More

Investor Alerts

If you would like to receive investor email alerts, simply complete this form. If you have already subscribed, you can change your settings or unsubscribe here.